← back to search

Amanda L. Christie

Massachusetts Institute of Technology · US
🔎 Find collaborators in Pathology and Forensic Medicine · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pathology and Forensic Medicine · Molecular Biology
Research interest
Research interests include Cancer research, Biology, Lymphoma, Medicine, Enhancer, and Transcription factor.
h-index
citations
2,217
works
14
NIH funding
primary concept
email

Recent publications

The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer
npj Breast Cancer 2025cited by 5position: middledoi
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
Cancer Discovery 2019cited by 58position: middledoi
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Nature Communications 2018cited by 113position: middledoi
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Cancer Research 2017cited by 128position: middledoi
A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas
Cell Reports 2017cited by 85position: middledoi
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Cancer Cell 2016cited by 303position: middledoi
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
Blood 2016cited by 84position: middledoi
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Blood 2016cited by 42position: middledoi
Mediator kinase inhibition further activates super-enhancer-associated genes in AML
Nature 2015cited by 404position: middledoi
Proxe: A Public Repository of Xenografts to Facilitate Studies of Biology and Expedite Preclinical Drug Development in Leukemia and Lymphoma
Blood 2015cited by 3position: middledoi
Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
Blood 2014cited by 480position: middledoi
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance
Nature Medicine 2014cited by 102position: middledoi
High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
Cancer Research 2013cited by 61position: middledoi
The Requirement for Cyclin D Function in Tumor Maintenance
Cancer Cell 2012cited by 349position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David M. Weinstock · Harvard University4 papers (2016–2019)Andrew L. Kung · Multimeric Biotherapeutics (United States)3 papers (2012–2014)Jon C. Aster · Harvard University3 papers (2016–2019)Aaron R. Thorner · Dana-Farber Cancer Institute2 papers (2013–2016)Scott J. Rodig · Massachusetts Institute of Technology2 papers (2016–2016)Michael Kluk · Cornell University1 papers (2017–2017) · 1 papers (2016–2016)Alexandria Van Scoyk · Dana-Farber Cancer Institute1 papers (2019–2019) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2016–2016)Paul G. Richardson · Harvard University1 papers (2014–2014)Simon T. Barry · AstraZeneca (United Kingdom)1 papers (2025–2025)Nikhil C. Munshi · Harvard University1 papers (2014–2014)Sabina Signoretti · Cancer Research Center1 papers (2012–2012) · 1 papers (2014–2014)Oliver Weigert · München Klinik1 papers (2016–2016) · 1 papers (2019–2019)Christian P. Pallasch · Integrated Oncology (United States)1 papers (2019–2019)Takaomi Sanda · National University of Singapore1 papers (2012–2012)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pathology and Forensic Medicine · Molecular Biology →